1

« Prev
1
Next »

1
Guest

1 Aug 26, 2008 22:30:51 GMT -5

Quote

Post by 1 on Aug 26, 2008 22:30:51 GMT -5

ÅÅÂÑÆÚ³öÑª ÈËÁ÷×ÉÑ¯ Í£¾ Í£¾ÔõÃ´°ì ÍâÒõ³¤Ð¡¸í´ñ ÍâÒõÑ÷ ÑªÄò ¼âÈñÊªðàÁÜ²¡ ÄòµÀ×ÆÈÈ ÄòÍ´ Òõ²¿³¤¸í´ñ Á÷²úÒ½Ôº Òõ²¿ÓÐÒìÎ¶ ¹¬¾±ÃÓÀÃÓëÊÜÔÐ ÔõÃ´²ÅÄÜ±ÜÔÐ ¸¾¿Æ×ÉÑ¯ ÔçÔÐ²âÊÔ »³ÔÐ Å®ÐÔ²»ÔÐ ÂÑ³²ÄÒÖ× ÁÜ²¡ ÉÏ»· ¸¾¿Æ²¡ ¸½¼þÑ× ÒõµÀÑ× ÅèÇ»Ñ× ×Ó¹¬ÄÚÄ¤Ñ× ¹¬¾±Ñ× ÒõµÀ½ôËõ Á÷²ú °×´øÒì³£

ÔÂ¾²»µ÷ ´¦Å®Ä¤ÐÞ²¹ ´¦Å®Ä¤ÐÞ²¹ Ò©ÎïÁ÷²ú ±±¾©¸¾¿ÆÒ½Ôº ¸¾¿Æ ¸¾¿ÆÒ½Ôº ¸¾¿ÆÑ×Ö¢ ×Ó¹¬¼¡Áö ÈËÁ÷ ÎÞÍ´ÈËÁ÷ ÈéÏÙÔöÉú ¸¾¿Æ¼ì²é ¹¬¾±ÃÓÀÃ ¹¬¾±Ï¢Èâ Ã·¶¾ Òõ¾¥¶ÌÐ¡ÔõÃ´°ì Òõ¾¥ÑÓ³¤ ÔçÐ¹ÄÜÖÎÂð ÖÎÁÆ¼âÈñÊªðà JJÎÊÌâ ZRLÖÎÁÆÇ°ÁÐÏÙ ØºÍèÌÛÍ´ ØºÍèÑ× ÒÅ¾«Õý³£Âð ¹êÍ·ºìµã º«Ê½ÉúÖ³ÕûÐÎ ¾«Òº´øÑªÔõÃ´°ì ÄÐ¿Æ×ÉÑ¯ Ç°ÁÐÏÙ×ÉÑ¯ Éä¾«ÌÛÍ´ ÉúÖ³Æ÷ðåÕî ÊÖÒù ¼âÈñÊªðà ¾«ÄÒÑ× ÒÅ¾« ÄòµÀÑ× ÖÌ´¯ Èõ¾«Ö¢ Ç°ÁÐÏÙÔöÉú Ç°ÁÐÏÙÖ×´ó ÐÔ¹¦ÄÜÕÏ° Ñôðô Ç°ÁÐÏÙÑ× °ü¾¥ °üÆ¤¹ý³¤ ¹êÍ·Ñ× ÔçÐ¹ Ç°ÁÐÏÙ¼²²¡ °üÆ¤ ÉúÖ³¸ÐÈ¾ ÄÐÐÔ²»Óý ±±¾©ÄÐ¿ÆÒ½Ôº ÄÐ¿Æ ÄÐ¿ÆÒ½Ôº ´÷¶û±Ê¼Ç±¾ ²»ÔÐ²»Óý Å£Æ¤Ñ¢ ÄÐ×°/·þÊÎ ÇéÈ¤ÄÚÒÂ ÃñÓªÒ½Ôº ÉÌÎñ³ÄÉÀ ÄÐÊ¿³ÄÉÀ ±±¾©¾©Ì³Ò½Ôº ÇéÈ¤ÄÚÒÂ ÌìÆÙ´ó¾Æµê ÌåÓý²ÊÆ± ±±¾©ÌÇÄò²¡·ÀÖÎÐ»á ¿ÚÇ»À£Ññ ´÷¶û±Ê¼Ç±¾µçÄÔ±¨¼Û ÎÞÍ´ÈËÁ÷ Å£Æ¤Ñ¢ÖÎÁÆ µç×ÓÏà²á ÖÆ×÷Ïà²á ¸ùÖÎÅ£Æ¤Ñ¢ ÈçºÎ¸ùÖÎÅ£Æ¤Ñ¢ ÖÐÒ©ÖÎÁÆÅ£Æ¤Ñ¢

jackier
Guest

1 Sept 24, 2008 23:33:14 GMT -5

Quote

Post by jackier on Sept 24, 2008 23:33:14 GMT -5

Johnson & Johnson said its experimental drug ustekinumab was more effective at treating the skin disease psoriasis than Amgen Inc.'s blockbuster drug Enbrel in a J&J-funded patient study.J&J, of New Brunswick, N.J., already has applied for Food and Drug Administration approval to market ustekinumab, supported by previous studies in which the drug was shown to be superior to a placebo in treating psoriasis. The newest study is unlikely to play a major role in the FDA's impending decision.The FDA is expected to decide on ustekinumab by December, having extended its review in August to allow more time to examine amendments to J&J's application. An FDA advisory committee in June recommended the drug be approved, but the agency isn't bound by the panel's advice. Analysts expect the drug, if approved, to generate hundreds of millions of dollars in sales within a few years.wow gold wow gold wow gold wow power leveling wow power leveling wow power leveling warhammer gold warhammer gold warhammer gold buy warhammer gold buy warhammer gold buy warhammer goldThe latest data for ustekinumab were presented Thursday at a dermatologists' meeting in Paris. In the 903-patient trial, participants with moderate to severe psoriasis received one of two dose levels of ustekinumab, or Enbrel. Lotro gold Lotro gold Lotro gold Ffxi gil Ffxi gil Ffxi gil Maple story mesos Maple story mesos Maple story mesos buy wow gold buy wow gold buy wow gold cheap wow gold cheap wow gold cheap wow goldThe main goal was to track the proportion of patients in each group who achieved at least a 75% reduction in psoriasis at 12 weeks, as measured by an index assessing the surface area and severity of the disease, Lotr gold Lotr gold Lotr gold Aoc gold Aoc gold Aoc gold Age of conan gold Age of conan gold Age of conan gold Aoc power leveling Aoc power leveling Aoc power levelingwhich causes skin lesions.J&J said 68% of those taking the lower dose of ustekinumab and 74% taking the higher dose achieved at least a 75% reduction in disease, versus 57% of Enbrel users reaching that mark.cheap ffxi gil cheap ffxi gil cheap ffxi gil Final fantasy xi gil Final fantasy xi gil Final fantasy xi gil Flyff penya Flyff penya Flyff penya Maple story meso Maple story meso Maple story meso Maplestory mesos Maplestory mesos Maplestory mesos "We've never really seen clearance [of psoriasis] along the lines of what we've seen with ustekinumab," said Alan Menter, a dermatologist with Baylor Research Institute in Dallas and one of the trial's lead investigators. Runescape gold Runescape gold Runescape gold Runescape money Runescape money Runescape money Silkroad gold Silkroad gold Silkroad goldDr. Menter said he has conducted research funded by other psoriasis-drug manufacturers, including Amgen.Amgen spokeswoman Sonia Fiorenza said the study "does not address long-term safety" because it only lasted 12 weeks. warhammer gold warhammer gold warhammer gold buy warhammer gold buy warhammer gold buy warhammer gold She noted Enbrel has a "consistent safety profile" and 16 years of clinical experience.Enbrel was introduced in 1998 as a treatment for rheumatoid arthritis. Following regulatory approval for additional uses including treatment of psoriasis, it is now one of the best-selling drugs in the world, with $5.3 billion in global sales last year, according to IMS Health.

shopbuynet
Goddess

Posts: 480

1 Feb 23, 2012 3:34:36 GMT -5

Quote

Post by shopbuynet on Feb 23, 2012 3:34:36 GMT -5

shopbuynet
Goddess

Posts: 480

1 Feb 23, 2012 20:33:13 GMT -5

Quote

Post by shopbuynet on Feb 23, 2012 20:33:13 GMT -5

shopbuynet
Goddess

Posts: 480

1 Feb 26, 2012 1:57:26 GMT -5

Quote

Post by shopbuynet on Feb 26, 2012 1:57:26 GMT -5

shopbuynet
Goddess

Posts: 480

1 Mar 7, 2012 0:55:34 GMT -5

Quote

Post by shopbuynet on Mar 7, 2012 0:55:34 GMT -5

shopbuynet
Goddess

Posts: 480

1 Apr 7, 2012 23:09:13 GMT -5

Quote

Post by shopbuynet on Apr 7, 2012 23:09:13 GMT -5

LDS Young Women

1

Post by 1 on Aug 26, 2008 22:30:51 GMT -5

Post by jackier on Sept 24, 2008 23:33:14 GMT -5

Post by shopbuynet on Feb 23, 2012 3:34:36 GMT -5

Post by shopbuynet on Feb 23, 2012 20:33:13 GMT -5

Post by shopbuynet on Feb 26, 2012 1:57:26 GMT -5

Post by shopbuynet on Mar 7, 2012 0:55:34 GMT -5

Post by shopbuynet on Apr 7, 2012 23:09:13 GMT -5

Quick Reply